385.30MMarket Cap
LossP/E TTM
X4 Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-23The current valuation score of X4 Pharmaceuticals Inc is 7.37, ranking 125 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -1.22, which is -16179.16% below the recent high of 195.65 and -25886.14% above the recent low of -316.20.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.